Foundation Medicine ($FMI) is rolling out a cancer genomics software system for next-generation sequencing (NGS) tests, building out its offerings amid an ...
Foundation Medicine (NASDAQ:FMI) announces that the U.S. Centers for Medicare & Medicaid Services (CMS) has OK'd reimbursement for its FoundationOne CDx comprehensive next-generation sequencing (NGS) ...
National Maintenance Cost for Precision Diagnostics Under the Verifying Accurate Leading-Edge In Vitro Clinical Test Development (VALID) Act of 2020 This was a retrospective study of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback